ApopLogic Overview
- Year Founded
-
2005

- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
ApopLogic General Information
Description
Operator of a biopharmaceutical company intended to focus on developing and commercializing novel cancer therapeutics. The company focused on the development and commercialization of Breceptin, an oncolytic drug for the treatment of a wide range of solid tumors, which induces cancer cell apoptosis by targeting specific receptors on the surface of the tumor cells, enabling patients to provide treatment of cancers and a unique oncolytic drug.
Contact Information
Website
www.apoplogic.comCorporate Office
- 12635 East Montview Boulevard
- Suite 100
- Aurora, CO 80045
- United States
Corporate Office
- 12635 East Montview Boulevard
- Suite 100
- Aurora, CO 80045
- United States
ApopLogic Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 01-Jan-2018 | Completed | Clinical Trials - General | |||
4. Grant | 31-Aug-2009 | Completed | Startup | |||
3. Angel (individual) | 11-Mar-2009 | Completed | Startup | |||
2. Grant | 24-Aug-2006 | $10K | Completed | Startup | ||
1. Grant | 01-Jan-2006 | $665K | Completed | Startup |
ApopLogic Patents
ApopLogic Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140294754-A1 | Use of tumor fas expression to determine response to anti-cancer therapy | Active | 14-Apr-2011 | ||
US-10352936-B2 | Use of tumor fas expression to determine response to anti-cancer therapy | Active | 14-Apr-2011 |
ApopLogic Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Xandex Ventures | Corporate Venture Capital | Minority | ||
Life Science Angels | Angel Group | Minority | ||
University License Equity Holding | Corporation | Minority | ||
InteractiveWest | Corporation | |||
U.S. Department of Health and Human Services | Government |
ApopLogic FAQs
-
When was ApopLogic founded?
ApopLogic was founded in 2005.
-
Where is ApopLogic headquartered?
ApopLogic is headquartered in Aurora, CO.
-
What industry is ApopLogic in?
ApopLogic’s primary industry is Drug Discovery.
-
Is ApopLogic a private or public company?
ApopLogic is a Private company.
-
What is ApopLogic’s current revenue?
The current revenue for ApopLogic is
. -
How much funding has ApopLogic raised over time?
ApopLogic has raised $795K.
-
Who are ApopLogic’s investors?
Xandex Ventures, Life Science Angels, University License Equity Holding, InteractiveWest, and U.S. Department of Health and Human Services have invested in ApopLogic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »